Sociedad Quimica Y Minera De Chile Sa Pfd Series A · BCS:SQM_A

Sociedad Quimica Y Minera De Chile Sa Pfd Series A — SQM — Investor Presentation (March 2010)

19 slides from Sociedad Quimica Y Minera De Chile Sa Pfd Series A's investor presentation, March 2010

  1. Slide 1: SQM S.A. Corporate Presentation

    SQM S.A. Corporate Presentation March 2010

  2. Slide 2: Important Notice

    Important Notice Statements in this presentation concerning the Company’s business outlook or future economic performances, anticipated profitability, revenues, expenses, or other financial items, anticipated cost synergies and product or service line growth, together with other statements that are

  3. Slide 3: World Leader in Specialty Businesses

    World Leader in Specialty Businesses 2009 2008 • Revenues US$ M 1,437 1,774 • Operating Income US$ M 442 632 • Net Income US$ M 327 501 Specialty Plant Nutrition Iodine & Derivatives Lithium & Derivatives 50% world market share 25% world market share 31% world market share Revenues US$649 M Revenues

  4. Slide 4: Unique Natural Resources

    Unique Natural Resources Foundation of our competitive advantage Caliche Ore Salar Brines Nitrates Potassium Iodine Lithium NaNO3 + KCl = KNO3 + NaCl (salt) 4

  5. Slide 5: Unique Natural Resources

    Unique Natural Resources Reserves Nitrates* 36.7 Iodine* 0.3 Lithium** 0.9 Potassium Chloride** 29.4 Salar Brines *millions of metric tons based on proven and probable reservesCaliche Ore **millions of metric tons based on proven reserves Source: 2008 Form 20-F • Caliche • Our caliche reserves estim

  6. Slide 6: Diversified Cash Flows

    Diversified Cash Flows Diversification by markets, products and customers Europe 27% North Am. 27% Asia & Oceania Africa & Mid.East 20% Latin Am. 11% 15% • Geographic distribution of exports during 2009 • 84% of sales are exports • Sales in more than 100 countries – Local presence in 20 countries 6

  7. Slide 7: Financial Performance

    Financial Performance EBITDA (*) Net Financial Debt (**) US$ millions US$ millions • During 2009 the Company increased its financial debt to finance its capex program and working capital increases. *EBITDA: operating income + depreciation (not including amortization) ** N.F.D. : interest bearing deb

  8. Slide 8: Financial Performance

    Financial Performance N.F.D. / EBITDA Cash and Cash Equivalents US$ millions • Cash plus committed credit lines add financial flexibility 8

  9. Slide 9: Potassium Chloride

    Potassium Chloride SQM can capture growth potential in Potassium market SQM Sales Volumes of KCl* Thous. MT Source: SQM Estimates *MOP is KCl or potassium chloride, also known as potash. • The increase in sales of potassium-based fertilizers is expected to have a significant effect on SQM’s margins.

  10. Slide 10: Specialty Plant Nutrition

    Specialty Plant Nutrition Historical world demand growth has averaged 5% Competitive Advantages Demand Drivers Demand for high- High cost of land Water value crops 100% Natural Origin Fully Water Soluble scarcity Fast Absorption Chlorine Free Regulates Soil Acidity + + SPN Products Modern agricultur

  11. Slide 11: Specialty Plant Nutrition

    Specialty Plant Nutrition Main Uses of KNO3: Premium Crops Vegetables (41%) Industrialized Crops (28%) Fruits (22%) Limited supply and increasing demand provide strong support for our KNO3 markets • Potassium nitrate (KNO3) capacity will increase by 300,000 MT in the second half of 2010 • No other r

  12. Slide 12: Iodine

    Iodine World leader with 25% market share LCD screens X-ray Contrast Media Salt Iodine World Market 2009 • Total demand: 25,500 TM. • World demand CAGR (2000-2008): 6% • Demand declined in 2009 • Competitors: ∗ Japan 25% ∗ Others Chile(Cosayach, Atacama Min, ACF) 28% ∗ Recycling 14% ∗ USA 5% ∗ Other

  13. Slide 13: Iodine

    Iodine SQM Sales Volumes* Iodine Demand and Prices** Price (US$/kg) Demand (Thous. MT) Thous. MT * Sales of iodine and iodine derivatives 13 ** Demand for iodine; iodine-equivalent price

  14. Slide 14: Lithium

    Lithium World leader with 31% market share Market Evolution* Main Uses* 1997: 45,000 MT 2009: 68,500 MT SQM 31% China 29% • World demand CAGR (1997 - 2008): 6.7% Others 1% • In 2009 demand was negatively affected by the crisis • In 2008, SQM expanded lithium carbonate FMC 20% Chemetall capacity from

  15. Slide 15: Lithium: Positive Outlook for Lithium Batteries

    Lithium Positive Outlook for Lithium Batteries • Current estimates suggest that between 2009-2012 approximately 10 car manufacturers will introduce HEV/EV using lithium batteries • By the year 2020, we estimate that between 8-9 million electric/hybrid cars will be produced per year. • Roughly 60-80%

  16. Slide 16: Industrial Nitrates

    Industrial Nitrates Solar Salts • Sales in the solar salts segment could consume 100% of the increase in nitrates production projected by SQM for the coming years • Main projects: • ACS Cobra-Sener, Man Solar Millenium, Abengoa, SAMCA, Solar Reserves. • New demand for industrial nitrates for thermal

  17. Slide 17: Capital Expenditure Plan

    Capital Expenditure Plan Focus on our main businesses • Capacity expansion for potassium nitrate in 300,000 MT per year • Capacity expansion for potassium-based products in the Salar de Atacama close to 600,000 MT per year • Other projects aimed at improving yields and reducing costs • Capex 2010 es

  18. Slide 18: Business Flexibility

    Business Flexibility Caliche Ore Salar Brines Iodine NaNO3 KCl SOP Lithium potassium sulfate sodium nitrate potassium chloride/ potash KNO3 potassium nitrate Specialty Chem. Ind. Chem. S.P.N. Fertilizer S.P.N. Specialty Chem. • World leader in iodine and lithium businesses market growth and low cost

  19. Slide 19: EBITDA Reconciliation

    EBITDA Reconciliation Millions of US$ 2009 2008 EBITDA 593.6 742.7 Depreciation (less) (151.7) (110.6) Operating Income 441.9 632.1 Non-operating Loss (less) (37.0) (19.3) Income Taxes (less) (76.5) (107.9) Other Items (less) (1.3) (3.5) Net Income 327.1 501.4 19

SQM — Investor Presentation (March 2010) on 6ix